This inventor holds 3 USPTO granted patents. Top assignees: Omex International Ltd., Other. Active years: 1976-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Norman, OK (US) (1976)
- Houston, TX (US) (1992 - 1993)
Company Filing History:
2 out of 3 
1 out of 834,513 Years Active: 1976-1993
Title: Alfred J Weinheimer: A Pioneer in Sickle Cell Anemia Treatment Innovations
Introduction
Alfred J Weinheimer, an accomplished inventor based in Houston, TX, has made significant contributions to the field of medical treatments, particularly concerning sickle cell anemia. With a total of three patents to his name, Weinheimer's dedication to innovation has helped shape potential therapies for patients suffering from this challenging condition.
Latest Patents
Weinheimer's most notable patents focus on the composition and method for the treatment of sickle cell anemia. His research has identified a major component in the carbonate fraction of free acids extractable from alfalfa, which has demonstrated excellent control of symptoms in patients with sickle cell disease. Through detailed analysis using proton NMR spectrometry, he established the structure of the compound as 16-hydroxy-9Z,12Z,14E-octadecatrienoic acid, along with related compounds such as esters, amides, triglycerides, and other derivatives of the carboxylic acid function. Furthermore, he developed a synthesis method from linseed oil or methyl linolenate, showing that the product from linseed oil, both as a triglyceride and as a free acid obtained via saponification, is beneficial for treating sickle cell disease.
Career Highlights
Throughout his career, Alfred J Weinheimer has worked with various organizations, including Omex International Ltd. His commitment to research and development, along with his innovative spirit, has propelled his work to the forefront of medical science.
Collaborations
In his pursuit of innovation and excellence, Weinheimer collaborated with Robert L Spraggins, leveraging their combined expertise to advance medical treatments.
Conclusion
Alfred J Weinheimer's contributions to the treatment of sickle cell anemia exemplify the impact of innovation on healthcare. His advancements not only highlight the importance of research in developing effective therapies but also encourage collaboration among innovators in the field. With a passion for science and a focus on patient well-being, Weinheimer continues to inspire future generations of inventors and researchers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile